Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMSO and ethanol inhalation spray for prevention and treatment of COVID-19
IRCT20200727048217N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of Dimethyl sulfoxide and ethanol in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoints: Oxygen saturation, Respiratory rate and 8 more. Started Aug 2020; status: completed.
02
Drugs
Dimethyl sulfoxideethanol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200727048217N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200727048217N1.